Top Anti Cancer Imported Medicine Drugs in India - Pharama Five
Help Desk :+916374297988

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org

Best Retevmo (Selpercatinib) Medicine in India

Buy Retevmo (Selpercatinib) Medicine in India

Retevmo (Selpercatinib)

Medicine name : Retevmo

Generic name : Selpercatinib

Manufactured By : Eli Lilly

Indications : Advanced or metastatic RET fusion +ve thyroid cancer

Medicine Description : Retevmo is a RET inhibitor for RET fusion-positive lung and thyroid cancers. It blocks abnormal RET proteins, reducing tumor growth. Taken orally, it is effective in resistant cases. Side effects include hypertension, liver toxicity, bleeding risks, and dry mouth. Blood pressure and liver function monitoring are needed.

Product Introduction

Retevmo (Selpercatinib) is a targeted anticancer treatment used for certain cancers that are driven by specific RET gene alterations. It is used in adults with advanced or metastatic RET fusion-positive non-small cell lung cancer (NSCLC), advanced or metastatic RET-mutant medullary thyroid cancer (MTC) requiring systemic treatment, and advanced or metastatic RET fusion-positive thyroid cancer requiring systemic treatment when radioactive iodine treatment is not appropriate or has not been effective. Selpercatinib helps target the underlying molecular changes that contribute to cancer growth and progression.

Retevmo (Selpercatinib) works by selectively inhibiting the activity of abnormal RET proteins, which can become continuously activated because of specific gene fusions or mutations. These abnormal RET signals can promote cancer cell growth and survival. By blocking RET signaling, Selpercatinib helps reduce the signals that support the growth and spread of cancer cells, making it a targeted treatment for cancers with specific RET alterations.

Retevmo (Selpercatinib) should be used exactly as prescribed by your doctor. Your healthcare professional may perform regular blood tests and other examinations during treatment to monitor liver function, blood pressure, heart rhythm, thyroid function, and your overall response to treatment. Inform your doctor about all medical conditions and medicines, vitamins, herbal products, or supplements you are taking before starting treatment. Report unusual or worsening symptoms, including severe diarrhea, significant changes in blood pressure, yellowing of the skin or eyes, unusual bleeding, or symptoms that may indicate heart or liver problems.

Uses Of Retevmo (Selpercatinib)

Treatment of RET-Altered Cancers

Benefits Of Retevmo

Retevmo (Selpercatinib) is used to treat certain RET-altered cancers, including RET fusion-positive non-small cell lung cancer (NSCLC), RET-mutant medullary thyroid cancer (MTC), and RET fusion-positive thyroid cancer. It works by selectively blocking abnormal RET signaling, which can contribute to cancer cell growth and survival. By inhibiting these signals, Retevmo (Selpercatinib) helps slow the growth and spread of cancer cells and can help control disease progression in patients whose tumors have specific RET alterations.

Side Effects Of Retevmo (Selpercatinib)

Some side effects of Retevmo (Selpercatinib) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Retevmo (Selpercatinib)

  • Dry mouth
  • Diarrhea
  • High blood pressure
  • Constipation
  • Rash
  • Headache
  • Fatigue
  • Swelling (edema)
  • Nausea
  • Increased liver enzymes
How To Use Retevmo

Take Retevmo (Selpercatinib) exactly as prescribed by your doctor. It is usually taken twice daily, approximately 12 hours apart, with or without food, depending on your doctor's instructions. Swallow it whole with water and do not crush, chew, or break it. Take each dose at approximately the same time each day. If you miss a dose and it is less than 6 hours until your next scheduled dose, skip the missed dose and take the next dose at the usual time. Do not take an extra dose to make up for a missed dose. Continue treatment for as long as recommended by your doctor.

How Retevmo (Selpercatinib) Works

Retevmo (Selpercatinib) is a targeted treatment that selectively blocks the activity of abnormal RET proteins. Certain RET gene fusions and mutations can cause RET signaling to remain continuously active, sending signals that promote cancer cell growth and survival. Selpercatinib binds to and inhibits these abnormal RET proteins, helping reduce the signals responsible for cancer growth and progression in tumors driven by specific RET alterations.

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Retevmo (Selpercatinib).

PregnancyCONSULT YOUR DOCTOR

Retevmo may cause serious harm to an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception during treatment and for the recommended period after the last dose, as advised by your doctor.

BreastfeedingCONSULT YOUR DOCTOR

Breastfeeding is not recommended during treatment with Retevmo and for the recommended period after the last dose. Consult your doctor for guidance on when breastfeeding can be safely resumed.

DrivingCONSULT YOUR DOCTOR

Retevmo may cause fatigue, dizziness, or other effects that can affect your ability to drive safely. Avoid driving if your alertness or ability to concentrate is affected.

KidneyCAUTION

Inform your doctor if you have kidney problems before starting treatment. Your doctor may recommend additional monitoring or dose adjustment depending on your kidney function.

LiverCAUTION

Tell your doctor if you have liver problems. Retevmo may affect liver function, so regular liver function tests and additional monitoring may be required.

Quick Tips
  • Take Retevmo (Selpercatinib) exactly as prescribed by your doctor and follow the recommended dosing schedule.
  • Take each dose at approximately the same time every day to maintain consistent treatment.
  • Swallow it whole with water and do not crush, chew, or break it.
  • Attend regular blood tests and medical check-ups as recommended by your doctor.
  • Inform your doctor promptly about persistent diarrhea, unusual tiredness, skin changes, or any other new or worsening symptoms.
  • Read More About - Retevmo (Selpercatinib) from Pharma Five.
Faq

General Question

Retevmo (Selpercatinib) is a prescription medication used to treat certain types of cancers, including non-small cell lung cancer (NSCLC), thyroid cancer, and other RET-positive tumors.

Retevmo is a kinase inhibitor that targets RET gene mutations or fusions, blocking cancer cell growth and helping to slow or stop tumor progression.

Doctors prescribe Retevmo for adults and children 12 years or older with RET-positive NSCLC, RET-mutant medullary thyroid cancer (MTC), or RET fusion-positive thyroid cancer.

Retevmo is taken orally in capsule form, usually twice daily, on an empty stomach (at least 2 hours before or after eating).

Common side effects include dry mouth, diarrhea, fatigue, swelling, high blood pressure, rash, and increased liver enzymes.

Yes, Retevmo may cause serious side effects such as liver problems, high blood pressure, bleeding, heart rhythm changes, or lung inflammation. Consult your doctor if severe symptoms occur.

Retevmo is typically taken as long as it remains effective and is well-tolerated, or until the doctor advises stopping treatment.

It is best to avoid alcohol while taking Retevmo, as it may worsen liver-related side effects and increase dizziness or fatigue.

No, Retevmo may harm an unborn baby. Women should use effective contraception during treatment and for some time after stopping the medication.

Yes, Retevmo may interact with certain antibiotics, antifungals, seizure medications, and stomach acid reducers. Inform your doctor about all medications you take.

If you miss a dose, take it as soon as possible, but skip it if the next dose is within 6 hours. Do not take two doses together.

No, Retevmo should be taken on an empty stomach, at least 2 hours before or after eating, to ensure proper absorption.

Avoid grapefruit, certain medications, excessive sun exposure, and ensure regular health check-ups while taking Retevmo.

Store Retevmo at room temperature, away from moisture and heat, and keep it out of reach of children.

Retevmo is available by prescription at specialty pharmacies. Consult your doctor for guidance on obtaining it. Pharma Five assists in its procurement.